JP2023530335A5 - - Google Patents
Info
- Publication number
- JP2023530335A5 JP2023530335A5 JP2022577390A JP2022577390A JP2023530335A5 JP 2023530335 A5 JP2023530335 A5 JP 2023530335A5 JP 2022577390 A JP2022577390 A JP 2022577390A JP 2022577390 A JP2022577390 A JP 2022577390A JP 2023530335 A5 JP2023530335 A5 JP 2023530335A5
- Authority
- JP
- Japan
- Prior art keywords
- relaxin
- section
- chain
- heterodimer fusion
- heterodimer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025279747A JP2026053559A (ja) | 2020-06-17 | 2025-12-24 | ヘテロ二量体リラキシン融合物及びその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063040250P | 2020-06-17 | 2020-06-17 | |
| US63/040,250 | 2020-06-17 | ||
| PCT/EP2021/066309 WO2021255127A1 (en) | 2020-06-17 | 2021-06-16 | Heterodimeric relaxin fusions and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025279747A Division JP2026053559A (ja) | 2020-06-17 | 2025-12-24 | ヘテロ二量体リラキシン融合物及びその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023530335A JP2023530335A (ja) | 2023-07-14 |
| JP2023530335A5 true JP2023530335A5 (cg-RX-API-DMAC7.html) | 2024-09-19 |
| JP7797423B2 JP7797423B2 (ja) | 2026-01-13 |
Family
ID=76584509
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022577390A Active JP7797423B2 (ja) | 2020-06-17 | 2021-06-16 | ヘテロ二量体リラキシン融合物及びその使用 |
| JP2025279747A Pending JP2026053559A (ja) | 2020-06-17 | 2025-12-24 | ヘテロ二量体リラキシン融合物及びその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025279747A Pending JP2026053559A (ja) | 2020-06-17 | 2025-12-24 | ヘテロ二量体リラキシン融合物及びその使用 |
Country Status (17)
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023086913A2 (en) | 2021-11-11 | 2023-05-19 | Tectonic Therapeutic, Inc. | Relaxin-2 fusion protein analogs and methods of using same |
| JP2025517100A (ja) | 2022-05-07 | 2025-06-03 | 北京拓界生物医薬科技有限公司 | リラキシン又は類似体の融合タンパク質及びその医薬的使用 |
| WO2024015634A2 (en) * | 2022-07-15 | 2024-01-18 | Nutcracker Therapeutics, Inc. | Mrna therapies including sirp-alpha |
| IL321288A (en) | 2022-12-09 | 2025-08-01 | Astrazeneca Ab | Dosing regimens using fusions of relaxin heterodimers |
| WO2024184206A1 (en) | 2023-03-03 | 2024-09-12 | Astrazeneca Ab | Pharmaceutical formulation comprising heterodimeric relaxin fusion proteins and uses thereof |
| EP4713001A2 (en) | 2023-05-18 | 2026-03-25 | Tectonic Operating Company, Inc. | Relaxin-2 fusion protein analogs and methods of using same |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1355919B1 (en) | 2000-12-12 | 2010-11-24 | MedImmune, LLC | Molecules with extended half-lives, compositions and uses thereof |
| US8389475B2 (en) * | 2009-08-10 | 2013-03-05 | The Board Of Trustees Of The Leland Stanford Junior University | Relaxin analogs |
| CN103429620B (zh) | 2010-11-05 | 2018-03-06 | 酵活有限公司 | 在Fc结构域中具有突变的稳定异源二聚的抗体设计 |
| AU2012280474A1 (en) | 2011-07-01 | 2014-01-16 | Bayer Intellectual Property Gmbh | Relaxin fusion polypeptides and uses thereof |
| US9574010B2 (en) * | 2011-11-04 | 2017-02-21 | Zymeworks Inc. | Stable heterodimeric antibody design with mutations in the Fc domain |
| AR094147A1 (es) * | 2012-12-27 | 2015-07-15 | Bayer Pharma Aktiengellschaft | Polipeptidos de fusion con actividad de relaxina y sus usos |
| DK3107938T3 (da) * | 2014-05-28 | 2022-07-11 | Zymeworks Inc | Modificerede, antigenbindende polypeptidkonstrukter og anvendelser heraf |
| US11161891B2 (en) * | 2015-12-09 | 2021-11-02 | The Scripps Research Institute | Relaxin immunoglobulin fusion proteins and methods of use |
| WO2018138170A1 (en) * | 2017-01-25 | 2018-08-02 | Medimmune, Llc | Relaxin fusion polypeptides and uses thereof |
-
2021
- 2021-06-16 CR CR20230015A patent/CR20230015A/es unknown
- 2021-06-16 MX MX2022016340A patent/MX2022016340A/es unknown
- 2021-06-16 CA CA3186143A patent/CA3186143A1/en active Pending
- 2021-06-16 CN CN202180042080.5A patent/CN115916813B/zh active Active
- 2021-06-16 KR KR1020237001632A patent/KR20230024994A/ko active Pending
- 2021-06-16 AU AU2021290997A patent/AU2021290997C1/en active Active
- 2021-06-16 JP JP2022577390A patent/JP7797423B2/ja active Active
- 2021-06-16 WO PCT/EP2021/066309 patent/WO2021255127A1/en not_active Ceased
- 2021-06-16 BR BR112022025019A patent/BR112022025019A2/pt unknown
- 2021-06-16 US US17/348,825 patent/US11795205B2/en active Active
- 2021-06-16 EP EP21734103.1A patent/EP4168434A1/en active Pending
- 2021-06-16 IL IL298786A patent/IL298786A/en unknown
- 2021-06-17 TW TW110122051A patent/TWI899263B/zh active
- 2021-06-17 AR ARP210101647A patent/AR125007A1/es unknown
-
2022
- 2022-12-15 CL CL2022003578A patent/CL2022003578A1/es unknown
-
2023
- 2023-01-03 CO CONC2023/0000038A patent/CO2023000038A2/es unknown
- 2023-01-16 EC ECSENADI20232960A patent/ECSP23002960A/es unknown
- 2023-07-01 US US18/346,205 patent/US12187774B2/en active Active
-
2024
- 2024-01-05 AU AU2024200074A patent/AU2024200074B2/en active Active
- 2024-11-25 US US18/958,082 patent/US20250230214A1/en active Pending
-
2025
- 2025-10-20 AU AU2025252658A patent/AU2025252658A1/en active Pending
- 2025-12-24 JP JP2025279747A patent/JP2026053559A/ja active Pending